|
Volumn 145, Issue 3, 2009, Pages 329-330
|
Treatment of cutaneous B-cell lymphoma, leg type, with age-adapted combinations of chemotherapies and rituximab
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BLEOMYCIN;
CHLORAMBUCIL;
CYCLOPHOSPHAMIDE;
CYTARABINE;
DOXORUBICIN;
EPIRUBICIN;
IBRITUMOMAB TIUXETAN;
METHOTREXATE;
PREDNISONE;
RITUXIMAB;
VINCRISTINE;
VINDESINE;
ADULT;
AGED;
ARTICLE;
B CELL LYMPHOMA;
CANCER COMBINATION CHEMOTHERAPY;
CANCER RADIOTHERAPY;
CANCER RELAPSE;
CANCER SURVIVAL;
CLINICAL ARTICLE;
FEMALE;
FOLLOW UP;
HEART FAILURE;
HUMAN;
INFECTION;
MALE;
NEUTROPENIA;
PNEUMONIA;
PRIORITY JOURNAL;
SEPSIS;
SEPTICEMIA;
SKIN LYMPHOMA;
THROMBOCYTOPENIA;
VEIN THROMBOSIS;
ADULT;
AGED;
AGED, 80 AND OVER;
ANTIBODIES, MONOCLONAL;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
FEMALE;
HUMANS;
LEG;
LYMPHOMA, LARGE B-CELL, DIFFUSE;
MALE;
MIDDLE AGED;
PREDNISONE;
SKIN NEOPLASMS;
VINCRISTINE;
|
EID: 62649096710
PISSN: 0003987X
EISSN: 15383652
Source Type: Journal
DOI: 10.1001/archdermatol.2009.23 Document Type: Article |
Times cited : (30)
|
References (6)
|